Rifampin

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Rifampin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

MonkeypoxMonkeypox

Coronavirus COVID-19 (SARS-CoV-2)Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 PandemicSuicide Risk in the COVID-19 Pandemic

Moderna COVID-19 VaccineModerna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 VaccineJohnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • All forms of tuberculosis.
  • Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.

NON-FDA APPROVED USES

  • Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
  • Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
  • Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
  • Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
  • Brucellosis
  • Bartonella infections
  • Q-fever and rickettsialinfections
  • Cutaneous leishmaniasis
  • Legionella infections
  • Anthrax infections
  • NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

  • All forms of tuberculosis.
  • Treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx.

NON-FDA APPROVED USES

  • Prosthetic valve endocarditis caused by staphylococci in combination with other agents (e.g. oxacillin/nafcillin, vancomycin) after blood cultures have cleared.
  • Prosthetic joint infections following debridement and retention of the prosthesis or 1-stage exchange.
  • Meningitis caused by penicillin and ceftriaxone resistant S. pneumoniae
  • Non-tuberculous mycobacterial infections (e.g. leprosy, MAC)
  • Brucellosis
  • Bartonella infections
  • Q-fever and rickettsialinfections
  • Cutaneous leishmaniasis
  • Legionella infections
  • Anthrax infections
  • NOTE: Rifampin is usually used in combination with other agents due to quick emergence of resistance if used as monotherapy.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2022 Unbound Medicine, Inc. All rights reserved